Walleye Trading LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,578,796
-68.2%
35,100
-71.7%
0.01%
-54.2%
Q1 2023$11,264,988
+2547.5%
123,900
+1006.2%
0.02%
+1100.0%
Q4 2022$425,488
-49.6%
11,200
-66.7%
0.00%0.0%
Q3 2022$844,000
+54.6%
33,600
+87.2%
0.00%
-33.3%
Q2 2022$546,000
+107.6%
17,951
+80.1%
0.00%
+200.0%
Q4 2021$263,000
-56.5%
9,965
+66.1%
0.00%
-66.7%
Q3 2021$604,000
+150.6%
6,000
+252.9%
0.00%
+200.0%
Q2 2021$241,000
-14.8%
1,700
-41.4%
0.00%
-50.0%
Q3 2020$283,000
+20.9%
2,900
+93.3%
0.00%0.0%
Q2 2020$234,000
+11.4%
1,500
+2.9%
0.00%
+100.0%
Q1 2020$210,000
-93.8%
1,458
-91.2%
0.00%
-95.7%
Q4 2019$3,373,000
+855.5%
16,500
+275.5%
0.02%
+1050.0%
Q3 2019$353,000
+67.3%
4,394
+96.2%
0.00%0.0%
Q2 2019$211,000
-12.1%
2,240
-20.3%
0.00%
+100.0%
Q1 2019$240,000
+12.7%
2,811
-26.0%
0.00%
-50.0%
Q4 2018$213,000
-16.1%
3,800
+22.6%
0.00%
+100.0%
Q3 2018$254,000
+10.4%
3,100
-53.0%
0.00%0.0%
Q2 2018$230,000
+11400.0%
6,592
+6492.0%
0.00%
Q1 2017$2,000
-95.8%
100
-95.5%
0.00%
Q4 2016$48,0002,2000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders